Managing Manufacturing Networks

• Chris Antoniou, Principal Engineer, Global Engineering and Technology, Biogen Idec
• Barak I. Barnoon, Director, Biotech Process Engineering, Pfizer Global Engineering, Pfizer Inc.
• Peter Latham, President, BioPharm Services US
• Duncan Low, Ph.D., Scientific Executive Director, Process Development, Amgen, Inc.
• Wolfgang Noe, Ph.D., Vice President, Bioprocess Development, Biogen Idec
• Curran Simpson, Senior Vice President, Operations, Human Genome Sciences, Inc.
• Victor A. Vinci, Ph.D., Director, Bioprocess Operations, Lilly Research Labs, Eli Lilly and Company

Process Development throughout the Product Lifecycle

• Shishir Gadam, Ph.D., Director, Manufacturing Science and Technology, Genentech Inc.
• Roger A. Hart, Ph.D., Scientific Director, Process & Product Engineering, Amgen
• Maninder Hora, Ph.D., Vice President, Product Operations, Facet Biotech
• Dr. Guenter Jagschies, Senior Director, Strategic Customer Relations, GE Healthcare Life Sciences, Sweden
• Howard L. Levine, Ph.D., President, BioProcess Technology Consultants, Inc.
• Ellen L. McCormick, Director, Primary Care and Oncology Portfolio, BioSciences Group, Pfizer Global Manufacturing, Pfizer, Inc
• Abhinav Shukla, Ph.D., Associate Director Manufacturing Sciences, Bristol-Myers Squibb

Recovery & Purification

• Amit Banerjee, Ph.D., Research Fellow, Global Biologics, Worldwide Pharmaceutical Sciences, Pfizer Inc.
• Chris Dowd, Ph.D., Senior Engineer, Late Stage Purification, Genentech, Inc.
• Sanchayita Ghose, Ph.D., Manager, Process Sciences Downstream, Bristol-Myers Squibb
• Ranga Godavarti, Drug Substance Development, Wyeth BioPharma (invited)
• Uwe Gottschalk, Ph.D., Vice President, Purification Technology, Sartorius Stedim Biotech, Germany
• David W. Kahn, Ph.D., Director, Late-Stage Purification Development, Human Genome Sciences, Inc.
• Natraj Ram, Ph.D., Senior Group Leader, Purification, Technical Operations, Abbott Bioresearch Center
• Tim Tressel, Ph.D., Director, Purification Process Development, Amgen, Inc.
• Peter W. Wojciechowski, Ph.D., Director, Process Development, Advanced Technologies and Regenerative Medicine, LLC (ATRM)

Cell Culture and Upstream Processing

• Susan Casnocha, Ph.D., Research Fellow, Bioprocess R&D, Culture Process Development, BioTherapeutics Pharmaceutical Sciences, Pfizer
• Martin Gawlitzek, Ph.D., Senior Scientist & Senior Group Leader, Late Stage Cell Culture, Process R&D, Genentech, Inc.
• Chetan T. Goudar, Ph.D., P.E., Head, Cell Culture Development, Global Biological Development, Bayer HealthCare
• Kevin Kayser, Ph.D., R&D Manager, Cell Culture Engineering, SAFC Biosciences
• Denny Kraichely, Ph.D., Associate Director, CMC Team Lead, Portfolio Management & Technical Integration, Johnson & Johnson Pharmaceutical R&D, Inc.
• Charles Sardonini, Ph.D., Associate Director, Process Engineering/Development, Genzyme Corp.
• Torsten W. Schulz, Ph.D., Associate Director, Biopharmaceutical Process Science, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
• Thomas Seewoester, Ph.D., Director, Process Development, Amgen Inc.
• Andrew Snowden, Ph.D., Senior Scientist, Cell Culture Development, Biogen Idec
• Gary J. Welch, Director, Process Science, Abbott Bioresearch Center
• Kelly Wiltberger, Senior Manager, Biopharm Development, Biogen Idec